| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Executive Chairman
2 companies
Martin John C is a Director at GILD, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 43 sales. Those positions are worth an estimated $399.6M at current prices.
Martin John C's largest disclosed position is in GILD as Director, worth about $399.5M. The recent filings there lean toward selling, a net 1,333,330 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2017 | GILD Gilead Sciences, Inc. | Executive Chairman | Sale+OE | 73,333 | $67.18 | $4,926,286.53 | -1.2% | |
| Mar 1, 2017 | GILD Gilead Sciences, Inc. | Executive Chairman | Sale+OE | 73,333 | $70.38 | $5,161,205.87 | -2.3% |